343 research outputs found

    Using dartmoor ponies in conservation grazing to reduce molinia caerulea dominance and encourage germination of Calluna vulgaris in heathland vegetation on Dartmoor, UK

    Get PDF
    The increasing dominance of purple moor-grass Molinia caerulea in heathland ecosystems in the UK is of growing concern due to its detrimental impact on plant and animal diversity on sites of nature conservation interest. The use of free-ranging ponies to reduce Molinia dominance was investigated from 2017 to 2019 within a 425 ha site on Dartmoor, UK. Salt blocks were used to attract the ponies to a Molinia-dominated area of heath within the site, away from their previously-preferred grazing areas. The impact of pony grazing was assessed by measurements of vegetation structure and plant species composition. The increased presence of ponies in the vicinity of the salt blocks increased the percentage occurrence of bare ground, reduced sward surface height, reduced percentage occurrence of Molina and increased the germination of heather Calluna vulgaris seedlings. The conclusions of this research are that salt blocks can be used to attract ponies to graze targeted areas of Molinia-dominated heathland. Through their grazing and trampling, ponies can reduce the dominance of Molinia, leading to an increase in the germination and establishment of heather seedlings

    Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D

    Get PDF
    Medulloblastoma is the most common malignant brain tumor of childhood. Despite numerous advances, clinical challenges range from recurrent and progressive disease to long-term toxicities in survivors. The lack of more effective, less toxic therapies results from our limited understanding of medulloblastoma growth. Although TP53 is the most commonly altered gene in cancers, it is rarely mutated in medulloblastoma. Accumulating evidence, however, indicates that TP53 pathways are disrupted in medulloblastoma. Wild-typep53-induced phosphatase 1 (WIP1 or PPM1D) encodes a negative regulator of p53. WIP1 amplification (17q22-q23) and its overexpression have been reported in diverse cancer types. We examined primary medulloblastoma specimens and cell lines, and detected WIP1 copy gain and amplification prevalent among but not exclusively in the tumors with 17q gain and isochromosome 17q (i17q), which are among the most common cytogenetic lesions in medulloblastoma. WIP1 RNA levels were significantly higher in the tumors with 17q gain or i17q. Immunoblots confirmed significant WIP1 protein in primary tumors, generally higher in those with 17q gain or i17q. Under basal growth conditions and in response to the chemotherapeutic agent, etoposide, WIP1 antagonized p53-mediated apoptosis in medulloblastoma cell lines. These results indicate that medulloblastoma express significant levels of WIP1 that modulate genotoxic responsiveness by negatively regulating p53

    Search for the glueball candidates f0(1500) and fJ(1710) in gamma gamma collisions

    Full text link
    Data taken with the ALEPH detector at LEP1 have been used to search for gamma gamma production of the glueball candidates f0(1500) and fJ(1710) via their decay to pi+pi-. No signal is observed and upper limits to the product of gamma gamma width and pi+pi- branching ratio of the f0(1500) and the fJ(1710) have been measured to be Gamma_(gamma gamma -> f0(1500)). BR(f0(1500)->pi+pi-) < 0.31 keV and Gamma_(gamma gamma -> fJ(1710)). BR(fJ(1710)->pi+pi-) < 0.55 keV at 95% confidence level.Comment: 10 pages, 3 figure

    Measurement of the Spectroscopy of Orbitally Excited B Mesons at LEP

    Get PDF
    We measure the masses, decay widths and relative production rate of orbitally excited B mesons using 1.25 million hadronic Z decays recorded by the L3 detector. B-meson candidates are inclusively reconstructed and combined with charged pions produced at the primary event vertex. An excess of events above the expected background in the B\pi mass spectrum in the region 5.6-5.8 GeV is interpreted as resulting from the decay B_u,d^** -> B^(*)\pi, where B_u,d^** denotes a mixture of l=1 B-meson states containing a u or a d quark. A fit to the mass spectrum yields the masses and decay widths of the B_1^* and B_2^* spin states, as well as the branching fraction for the combination of l=1 states. In addition, evidence is presented for the existence of an excited B-meson state or mixture of states in the region 5.9-6.0 GeV

    Search for Charged Higgs Bosons in e+e- Collisions at \sqrt{s} = 189 GeV

    Full text link
    A search for pair-produced charged Higgs bosons is performed with the L3 detector at LEP using data collected at a centre-of-mass energy of 188.6 GeV, corresponding to an integrated luminosity of 176.4 pb^-1. Higgs decays into a charm and a strange quark or into a tau lepton and its associated neutrino are considered. The observed events are consistent with the expectations from Standard Model background processes. A lower limit of 65.5 GeV on the charged Higgs mass is derived at 95 % confidence level, independent of the decay branching ratio Br(H^{+/-} -> tau nu)

    Search for the standard model Higgs boson at LEP

    Get PDF

    Neurodevelopmental risk factors in schizophrenia

    Get PDF
    The authors review environmental and neurodevelopmental risk factors for schizophrenic disorders, with emphasis on minor physical anomalies, particularly craniofacial anomalies and dermatoglyphic variations. The high prevalence of these anomalies among schizophrenic subjects supports the neurodevelopmental theory of the etiology of schizophrenia, since they suggest either genetically or epigenetically controlled faulty embryonic development of structures of ectodermal origin like brain and skin. This may disturb neurodevelopment that in turn may cause these subjects to be at increased risk for the development of schizophrenia and related disorders. The precise confirmation of this theory, at least in some cases, will provide further understanding of these illnesses, allowing easy and inexpensive identification of subjects at risk and providing guidelines for the development of new pharmacological interventions for early treatment and even for primary prevention of the illness
    corecore